|Year : 2014 | Volume
| Issue : 2 | Page : 39-47
Sleep apnea and occupational accidents: Are oral appliances the solution?
Maria De Lourdes Rabelo Guimar„es1, Ana Paula Hermont2
1 Faculty of Dentistry of the Federal University of Minas Gerais, Belo Horizonte, Brazil
2 Department of Pediatric Dentistry and Orthodontics, Faculty of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
|Date of Web Publication||12-Dec-2014|
Maria De Lourdes Rabelo Guimar„es
Faculty of Dentistry of the Federal University of Minas Gerais, Belo Horizonte
Source of Support: None, Conflict of Interest: None
Background: Dental practitioners have a key role in the quality of life and prevention of occupational accidents of workers with Obstructive Sleep Apnea Syndrome (OSAS). Aim: The aim of this study was to review the impact of OSAS, the Continuous Positive Airway Pressure (CPAP) therapy, and the evidence regarding the use of oral appliances (OA) on the health and safety of workers. Materials and Methods: Searches were conducted in MEDLINE (PubMed), Lilacs and Sci ELO. Articles published from January 1980 to June 2014 were included. Results: The research retrieved 2188 articles and 99 met the inclusion criteria. An increase in occupational accidents due to reduced vigilance and attention in snorers and patients with OSAS was observed. Such involvements were related to excessive daytime sleepiness and neurocognitive function impairments. The use of OA are less effective when compared with CPAP, but the results related to excessive sleepiness and cognitive performance showed improvements similar to CPAP. Treatments with OA showed greater patient compliance than the CPAP therapy. Conclusion: OSAS is a prevalent disorder among workers, leads to increased risk of occupational accidents, and has a significant impact on the economy. The CPAP therapy reduces the risk of occupational accidents. The OA can improve the work performance; but there is no scientific evidence associating its use with occupational accidents reduction. Future research should focus on determining the cost-effectiveness of OA as well as its influence and efficacy in preventing occupational accidents.
Keywords: Continuous positive air pressure, obstructive sleep apnea, occupational accidents, oral appliances, review
|How to cite this article:|
Rabelo Guimar„es MD, Hermont AP. Sleep apnea and occupational accidents: Are oral appliances the solution?. Indian J Occup Environ Med 2014;18:39-47
|How to cite this URL:|
Rabelo Guimar„es MD, Hermont AP. Sleep apnea and occupational accidents: Are oral appliances the solution?. Indian J Occup Environ Med [serial online] 2014 [cited 2022 Jul 1];18:39-47. Available from: https://www.ijoem.com/text.asp?2014/18/2/39/146887
| Introduction|| |
The Obstructive Sleep Apnea Syndrome (OSAS) is characterized by repeated collapse of the upper airway during sleep, resulting in nocturnal hypoxemia and fragmented sleep. Associated brain dysfunctions can be expressed, such as abnormal daytime sleepiness and lack of concentration, and these are common causes of traffic accidents. ,,,
Several studies have associated OSAS with increased risk of traffic accidents , and the majority of the researches were conducted among professional drivers. Obtaining data on the frequency of sleep-disordered breathing, nocturnal sleep disruption, and excessive sleepiness among the working population is an important public health problem. , It is noteworthy that the identification and treatment of snoring and OSAS in workers can potentially reduce the number of occupational injuries, absenteeism, improve productivity, health, and wellbeing of these professionals. ,,,
Several well-tolerated and effective treatments for OSAS have demonstrated improvements in the quality of life and reduction in the use of health services and vehicle collisions. ,, Treatments for OSAS can be clinical or surgical, and the clinical treatment options include behavioral measures, and the use of continuous positive airway pressure device (CPAP) or oral appliances (OA). 
The OA are a noninvasive treatment option for patients with OSAS and it is considered less uncomfortable than CPAP.  The American Academy of Sleep Medicine recommends the OA therapy for patients with mild-to-moderate OSAS and those with severe OSAS who cannot tolerate CPAP and refuse surgery procedures. 
The use of CPAP is indicated as firstline treatment for people with high levels of apnea-hypopnea index (AHI) associated with excessive sleepiness  ; however, there are indications that OA improves subjective sleepiness and sleep-disordered breathing. 
Randomized trials assessing the effectiveness of OA found that it reduced the excessive daytime sleepiness when compared with patients without treatment. ,,,, Moreover, when the results of CPAP and OA were compared, there was no significant difference between both therapies. ,,,,
A randomized clinical trial presented improvements on energy and fatigue levels and vigilance and psychomotor speed among patients treated with OA when compared with placebo.  Other studies also found improvements in neurocognitive function using the OA, which did not differ statistically from the improvements achieved by the CPAP therapy. ,
In 2011, a longitudinal study was conducted with patients with mild-to-moderate OSAS who were randomized regarding the treatment for CPAP or OA. The study showed similar improvement from both therapies regarding the AHI and excessive daytime sleepiness; however, the survey sample was not representative.  It is worth noticing that changes in the oral appliances design may contribute to different results, once a study comparing devices with different designs showed differences in the improvement of excessive daytime sleepiness. 
The CPAP treatment significantly reduces the risk of accidents in OSAS patients. ,,,, Treatment with OA, in addition to being effective to normalize the respiratory disorders, improved work performance of patients with OSAS.  However, it still lacks a more comprehensive way to assess the benefit of OA on driving simulation and real driving performance.  This article aimed to revise the prevalence and impact of OSA on work performance, occupational impairments, use of health services, and its economic impact. The cost-effectiveness and effects of the CPAP therapy and especially the role of OA concerning those issues were also investigated.
| Materials and methods|| |
These were the inclusion criteria used in this article: Articles published from January 1980 to June 2014 concerning patients with a diagnosis of OSA, presenting AHI >5, snorers, upper airway resistance syndrome, age ≥18 years; any study design and the languages were restricted to: English, French, and Portuguese.
Exclusion criteria were central sleep apnea, coexisting sleep disorders, regular use of sedatives or narcotics, preexisting lung disease, and psychiatric illness. Searches were conducted on MEDLINE (PubMed), Latin American and Caribbean Literature Data on Health Sciences (LILACS) and Scientific Electronic Library Online (SciELO), in addition to searches from the references of the identified articles.
The search strategy was performed by combining the following descriptors: Apnea, snoring, sleepiness, mandibular advancement devices, oral appliances, continuous positive air pressure, cost, economics, cost-effectiveness, accident, health care utilization, driving, occupational accidents, occupational injury, traffic, commercial vehicle drivers, and work limitation. The analysis was based on critical readings of the articles content. Subsequently, the common contents were identified, grouped, and tabulated to form the thematic analysis and preparation of a critical discourse.
| Results and discussion|| |
During the search, 2188 articles were identified, but 2095 were excluded once they did not meet the inclusion criteria, totaling 99 articles included.
Impairments in occupational performance
Sleepiness negatively affects cognitive function, therefore it is assumed that patients with OSAS suffer impairments in labor capacity, ,,, by presenting lack of concentration and attention, memory impairment, and changes in the ability to perform everyday tasks and learning. Moreover, the reduced capacity for executive functions such as completing tasks, can cause loss of motivation and initiative. ,
The National Sleep Foundations (NSF) in the United States assessed the sleep of workers and found that those at risk for OSAS had a greater chance of having difficulty when performing cognitive tasks, including problems with concentration and organization and also a greater risk of falling asleep at work, decreased productivity, and absenteeism due to sleepiness.  Snoring was also highly associated with excessive sleepiness and work performance impairments. 
The sleep-disordered breathing was a common finding among Brazilian professional drivers who presented an OSAS prevalence of 38%. Furthermore, the daytime sleep was fragmented and shorter than nocturnal sleep and more drivers presented extreme sleepiness. It is worth noticing that such deficiencies of sleep can negatively affect performance in driving.  Another epidemiological study conducted among Brazilian railroad workers suggested age, body mass index (BMI), and alcohol consumption as associated with an increased risk of developing OSAS and it stressed the need for greater attention to this population, once they are more prone to suffer accidents. 
In Greece, the prevalence of sleep-disordered breathing among drivers of rail transport was similar to other studies, but the study reported a low prevalence of drowsy drivers (7.1%). However, this data has to be carefully analyzed once it was used a subjective evaluation criterion by Epworth Sleepiness Scale. 
Among a group of American officers, sleep disorder was identified as an ordinary problem and that it was significantly associated with increased risk of health problems, work performance, and safety outcomes; OSAS was the most prevalent disorder (33.6%). Excessive sleepiness was found in 28.5% of the police officers and there was an increase in the prevalence of physical and mental health disorders, including diabetes, depression, cardiovascular disease, and increased risk of accidents. 
A study carried out among soldiers identified that 88.2% of the sample were diagnosed with sleep disorders. Insomnia coexisting with OSAS was found in 38.2% of the military and they were significantly more likely to meet criteria for depression compared with control subjects and others with only OSAS.  Among young soldiers in Korea, it was found that the prevalence of snoring and high risk of OSAS was 13.5% and 8.1%, respectively. It is worth noticing that this is not a low prevalence considering that the individuals were young and not obese. 
It was observed that the treatment of OSAS resulted in the reduction of occupational accidents and improved the performance of employees. Therefore, it is advisable to develop strategies for screening effective treatment of OSAS.  Nevertheless, it has been difficult to establish the exact effect of untreated OSAS in real driving and traffic accidents. Driving simulators have been used as a cheaper and safer reproducible way to assess the effect of OSAS on different aspects of driving, but despite the benefits provided, the simulator cannot measure all the aspects experienced in a real-life driving situation. 
In Canada, useful data from a study of driving in "real life" were evaluated. Over a period of three years patients with mild, moderate, and severe OSAS had an increased rate of traffic accidents when compared with drivers without this condition and had higher rates of road traffic accidents associated with personal injury.  Worse performances in driving simulators among subjects with untreated OSAS was also identified by other studies. ,, Nonetheless, after treatment with CPAP, there was an improvement in the driving performance. ,, It is known that the CPAP therapy improves driving performance and can potentially reduce the risk of accidents, but the benefits provided by CPAP depend on treatment adherence. 
The results of a study conducted in 2011 suggest persistent impairment in driving simulator during long trips in patients with severe OSAS treated with CPAP. These results support the evidence that some neurobehavioral deficits in patients with severe OSA are not fully reversed by treatment. More controlled studies with larger samples are needed to confirm these findings and further researches should investigate the causes of residual driving simulator impairment among patients with OSAS treated with CPAP and its association with increased risk of vehicular accident on highway. 
Test driving simulator was also used to investigate whether OSAS patients had worse labor performance than healthy drivers. The benefits provided by OA and CPAP were also analyzed. The results showed a significantly higher number of lapses in attention among OSAS patients. The total number of lapses of attention was significantly decreased after both therapies, with OA and CPAP, with no significant differences between the two types of treatment. 
However, a more comprehensive way to assess the benefits of OA on driving simulation tests, and real-life driving performance are needed to adequately assess its potential role concerning the risk of drowsiness at the wheel represented by OSA. 
Another important issue that should be discussed concerning the impairments in occupational performance is related to the international driving licensing legislation. A committee established by the European Commission on sleep apnea and driving has been discussing about directives with an approach to patients with moderate or severe sleep apnea, particularly associated with significant sleepiness. Those patients will be prevented from driving, or at least will be prevented from holding a driver's license, until the condition is successfully treated. 
The driving licenses may be issued to applicants or drivers with moderate or severe OSAS who show adequate control of their condition and compliance with appropriate treatment and improvement of sleepiness, if any, confirmed by authorized medical opinion. Applicants or drivers with moderate or severe OSAS under treatment shall be subject to a periodic medical review with a view to establish the level of compliance with the treatment, the continued good vigilance, and evaluate the need for continuing the treatment. 
Many mental functions are reduced in situations of fatigue and sleepiness.  It is estimated that 20% of accidents are caused by drivers' inattention and sleepiness,  and the occurrence of drowsiness when driving is a major risk factor for dangerous accidents.  Chronic excessive sleepiness and sleep-disordered breathing were common in a sample of drivers of commercial vehicles in Australia. Sixty percent of drivers had OSAS and 16% had OSAS with excessive daytime sleepiness.  Drivers with a high risk for OSAS and a work schedule with little chance of rest reported more daytime sleepiness and poor sleep quality in a study conducted among Belgian truckers  and Japanese bus drivers. 
In Brazil, 16% of professional drivers admitted having fallen asleep at the wheel; however, this number increased to 58% when it was reported by colleagues. It was observed that respiratory disorders and snoring are some causes of fragmentation or reduction of rapid eye movement (REM) sleep, which could support the hypothesis that REM sleep deprivation can lead to common complaints such as mental fatigue, irritability, and sleepiness among professional drivers. 
Nowadays, most European countries have traffic laws directed to sleep-disordered breathing.  The driver screening methods should contain questions about drowsiness at the wheel, habitual snoring, and sleep apneas, as well as the Epworth Index and BMI.  After an assuredly effective and efficient treatment, including regular checkups for control and evaluation of symptoms, patients are allowed to drive. Nevertheless, during the interim period between the diagnosis and therapy, drivers can still be considered able to drive, but with limitations (eg, drive short distances and avoid driving on major highways or at night. ,
In Brazil, due to the high rate of traffic accidents caused by drowsiness, in 2008, a resolution was approved by the National Traffic Department to reduce the number of accidents caused by drowsiness, fatigue, sleep-disordered breathing, and changes in biological rhythms.  Evaluation of OSA was included in this resolution as well as the requirement of new medical and psychological examinations for all professional drivers. 
Sleep-related accidents comprise 16%-23% of all vehicle accidents.  Many of these accidents could be prevented by treating sleep-disordered breathing.  However, drivers with symptoms of drowsiness or sleep-disordered breathing may not report accidents due to concerns of losing their jobs, compromising the results of studies on the association between these disorders and accidents. 
A study conducted among long distance truck drivers in the United States found that about 20% of drivers presented symptoms of sleep disorders. Drivers who were working with the same company for over a year were more likely to have daytime fatigue, daytime tiredness, restless sleep, hypertension, and increased BMI.  Other studies observed a higher prevalence of OSAS in railway workers than in the general population, , thus necessitating greater attention to this population, due to the greater propensity for accidents.
A research conducted with presumably healthy working men also identified a significant association between the complaint of excessive daytime sleepiness and the incidence of sleep apnea.  In Turkey, 241 long-distance drivers were interviewed about symptoms of OSAS, and occupational history. The drivers who had evidence of OSAS underwent polysomnography. Snoring was detected in 56% of all participants and daytime sleepiness was observed in 26.6%. The prevalence of OSAS was 14.1%. There was a significant relationship between the rate of traffic accidents by professionals/year and AHI, lowest saturation, desaturation index, and arousal index. The disease severity was directly proportional to the risk of accidents. 
Snoring, which is one of the signals present in OSAS, has been associated with increased risk for accidents and morbidity. A study conducted in Hungary found that snoring is common in the adult population. Through interviews, the study showed that especially loud snoring with breathing pauses was strongly associated with health impairment, higher comorbidity, daytime sleepiness, and a higher frequency of accidents. 
A retrospective evaluation of snoring workers due to suggestive symptoms of OSAS found a significantly higher frequency of occupational accidents among these professionals when compared to the general population of snorers. In this study, all subjects underwent overnight polysomnography in a sleep laboratory and, interestingly, the risk of accidents was high among heavy snorers without apnea and patients with OSAS. 
A prospective study found that men who reported both snoring and excessive daytime sleepiness were with an increased risk of labor accidents during the 10 years of follow-up.  The high risk of traffic accidents among drowsy drivers was mainly determined by the respiratory effort-related arousals (RERA) than by the presence of apneas and hypopneas.  The RERAs are secondary to upper airway obstructions during sleep and can occur in the absence of apneas and hypopneas, causing excessive daytime sleepiness.
Studies using the esophageal pressure measure were performed in habitually sleepy drivers and drivers without this condition. Sleepy drivers with apnea had higher accident rates in five years than drivers in the control group. Nevertheless, a high rate of RERA, but not sleep apnea, was still a risk factor among drivers habitually sleepy. These findings confirm the importance of identifying RERA in routine examinations in sleep laboratories. 
Just like it occurs with civilians, excessive sleepiness is a risk to the safety of military that operate dangerous vehicles, machinery, or carry firearms. Military with untreated OSA are also at risk for suffering from decreased mental alertness and decreased cognitive function due to drowsiness. Military with mild-to-moderate OSA and upper airway resistance syndrome (UARS) often have abnormal results in the Maintenance of Wakefulness Test and therefore have a pathological tendency to fall asleep. A study conducted in 2009 among military personnel identified that 32% of the sample had UARS and 68% OSA. 
Effectiveness and efficacy of CPAP and oral appliances
The physician must diagnose sleep apnea and evaluate the patient's risk for injuries. The patient should be informed about the risks and an appropriate treatment should be instituted. In addition, the doctor should provide a follow-up plan to determine if the treatment has decreased the patient's risk for accidents. 
Although many investigations have pointed out that treatment of primary snoring and OSAS with CPAP or OA contributes to the reduction of vehicle and labor accidents, ,,,, this review did not find any studies evaluating the effectiveness of OA regarding this outcome.
Like several other medical treatments, the efficacy of CPAP or OA depends on the degree of identification of OSAS and the degree of adherence to the treatment among the diagnosed individuals.  Treatment with CPAP reduces the risk of accidents because it is used by the patient.  Nonetheless, adherence to CPAP continues to be a major problem when treating OSAS, although more recent data suggest that adherence may have improved in recent years. However, a recent study found that only 5% of professional drivers diagnosed with OSAS showed adequate adherence to CPAP. ,
It is important to include the patients in the treatment decision, offering more than one type of therapy for patients with OSA. Despite the residual apneas with the use of OA, or the highest rate of effectiveness of CPAP in reducing AHI, the similarities between the results of such treatments may be related to the hours of use per night. The OA which are considered to have partial efficacy, when used for prolonged hours may lead to similar outcomes when compared with CPAP. 
The ability to pre-select suitable candidates for either treatment is important. Although some predictors of success with OA have been evaluated, further studies are needed to better predict which patient will have a higher level of success with the OA therapy.  Less obese patients with mild sleep apnea and certain craniofacial characteristics such as mandibular retrognathia proved to be good candidates for the OA therapy. 
When analyzing the economic impact of OSAS, it was highlighted that there was a lack of clarity concerning the epidemiology of accidents in patients correctly treated with CPAP. Furthermore, it was suggested that future studies are needed to evaluate the improvement in the labor activities of OSAS patients before and after treatment, as well as studies evaluating the cost-effectiveness between surgical and clinical treatments. 
Most studies regarding the adherence to OA use subjective measures to evaluate the therapy compliance.  Nevertheless, a study conducted in 2012 objectively evaluated the use of OA among patients undergoing therapy for OSA by means of a heat-sensitive microsensor, which was attached to the OA. The overall mean rate of OA use was 6.7 ± 1.3 h per day with a regular users' rate of 82%. Despite not having a statistically significant difference between the self-report and the use of microsensor, the safety and feasibility of using this device to objectively measure the OA's compliance was highlighted. 
Although, according to a systematic review, many studies have demonstrated the effectiveness of OA in reducing daytime sleepiness and improve the neurocognitive function,  the Federal Motor Carrier Safety Administration does not recommend the use of the OA in the treatment of OSAS among professional drivers, once there is no scientific evidence associating the reduction of accidents by using these devices and it is difficult to assess the patients' treatment adherence.  Furthermore, an updated version of the Thoracic Society Clinical Practice Guideline recommended the use of CPAP to reduce accidents, but again the OA were not listed due to lack of scientific evidence about the effects of this therapy on the risk of accidents. 
The OSAS treatment options may become limited by the conditions of the work environment. The diagnosis of sleep-disordered breathing may affect the deployable strength of the military personnel due to the difficulty they might face concerning the use of CPAP.  Military deployed in desert environment are at a risk of inhaling airborne particulate matter that can harm their health. In this condition, the CPAP therapy can facilitate the inhalation of these particles. Therefore, alternatives to solve this problem such as using foam filters have been tested. 
Economic impact of OSAS
Obstructive sleep apnea affects the daily lives of millions of people around the world and presents a growing economic impact. The evidence linking OSAS with various public health problems such as obesity, diabetes, depression, cardiovascular disease, and accidents has increased. 
It is estimated that in the United States, the total costs attributable to sleep apnea-related accidents is quite high. In 2000, 1400 people died due to vehicular collisions and in 2004 these accidents had a cost of $ 15.9 billion. With regard to the management of accidents, it is estimated that the treatment with CPAP for all drivers who suffer from OSAS would be of $ 3.18 billion. Even taking into account a treatment efficiency of only 70%, there would be a reduction of $ 11.1 billion in collision costs and 980 lives would be saved per year.  The literature suggests that treating 500 patients for three years would result in savings more than $ 1,000. 000. 
A more recent analysis of OSAS' treatment showed significantly lower costs of the treatment plan. In addition, it was also observed fewer disability claims; cost reduction for disability and fewer lost days of work.  A prospective study compared the effects of OSAS between men and women during 1994-2005. An increased risk of absenteeism in subjects with sleep apnea was observed. In women, the major risk was present five years before diagnosis, whereas in men the major risk was observed one year before the diagnosis of OSAS. 
Education campaigns encouraging members of health plans to seek specific treatment for sleep-disordered breathing resulted in substantial savings. Two years after the education campaign started, it was computed savings of U.S. $ 4,900.00. 
Dentists can play an important role in accident prevention through the detection of risk factors by screening their patients for OSAS, evaluating oral/jaws anatomical features, and screening for sleep disorders during the anamnesis. 
Use of health services and resources
Untreated obstructive sleep apnea predisposes patients to various morbidities and consequently increases the use of health services. ,,,, The risk assessment of OSAS among workers can help to reduce the national health care burden.  Evidence suggests that patients with untreated sleep apnea require a greater amount of health resources. Moreover, adherence to treatment in patients with OSAS results in a significant reduction in hospitalizations and medical applications. ,
In 2013 a study comparing the health effects after one month of CPAP and OA therapy identified that despite the CPAP therapy was more effective in reducing the AHI, the therapy with OA had greater adherence, hence both therapies showed similar results. 
Cost-effectiveness of OSAS treatment
Concerning CPAP therapy, studies in several countries have evaluated its cost-effectiveness ,, Some patients have to try more than one treatment option before control of OSAS is reached. Treatment should be individualized and supported by scientific evidence, and the evaluation of cost-effectiveness is also required. Information about the therapy cost is important for the governments, transport, industry, and insurance agencies to plan actions to decrease the economic impact of untreated OSAS. 
Data on types of treatment for snoring and OSAS suggested that therapy with OA had lower costs when compared with other treatment modalities.  Nonetheless, it has not been evaluated yet the use of OA associated with reduced risk of vehicle and labor accidents. Further studies should evaluate from a social perspective the loss of work productivity, increased absenteeism, insurance, and costs and assess the use of OA in preventing occupational accidents. 
The cost-effectiveness of CPAP was compared with the OA therapy and lifestyle advice using a method of quality-adjusted life year (QALY) in a life perspective. On average, CPAP was associated with higher costs than other therapies. However, in another analysis CPAP was more profitable than OA. Therefore, regarding adults who suffer from moderate or severe symptomatic OSA it was concluded that CPAP has better cost-effectiveness when compared with OA and lifestyle advice. 
The OA are now widely prescribed for the treatment of OSAS, either as a primary or as an alternative measure to those patients unwilling or unable to tolerate CPAP therapy. Although CPAP has been shown to be more effective than OA  and highly cost-effective,  there are increasing evidences that OA improve drowsiness, blood pressure, and indices of sleep-disordered breathing.  Moreover, many patients who respond to both treatments generally prefer to use OA. 
Despite the limited evidence on the cost-effectiveness of OA, through this literature review it can be observed that OA are economically less attractive than CPAP, but remain as a cost-effective treatment for patients who do not want or do not adhere to treatment with CPAP. 
| Conclusion|| |
This review highlights the fact that OSA is a prevalent disorder among works, leads to increased risk of occupational accidents, greater use of health services, and has a significant impact on the economy.
The CPAP therapy reduces the risk of occupational accidents. Furthermore, it has been shown to be cost-effective, improve the work performance, and reduce health burdens. Regarding OA, despite showing an improvement in work performance, there is no scientific evidence of occupational accidents reduction. Moreover, there is limited evidence of its cost-effectiveness and its effect on reducing the use of health services.
Due to the lack of evidence regarding the use of OA for occupational accidents, future research should focus on determining the cost-effectiveness, influence, and efficacy of these devices in preventing occupational accidents among workers who suffer from OSA.
| References|| |
Findley LJ, Weiss JW, Jabour ER. Drivers with untreated sleep apnea. A cause of death and serious injury. Arch Intern Med 1991;151:1451-2.
Strollo PJ Jr., Rogers RM. Obstructive sleep apnea. N Engl J Med 1996;334:99-104.
Teculescu D. Sleeping disorders and injury prevention of occupational or domestic accidents. Sante Publique 2007;19:147-52.
Ellen RL, Marshall SC, Palayew M, Molnar FJ, Wilson KG, Man-Son-Hing M. Systematic review of motor vehicle crash risk in persons with sleep apnea. J Clin Sleep Med 2006;2:193-200.
Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 1999;340:847-51.
Stoohs RA, Bingham LA, Itoi A, Guilleminault C, Dement WC. Sleep and sleep-disordered breathing in commercial long-haul truck drivers. Chest 1995;107:1275-82.
de Mello MT, Narciso FV, Tufik S, Paiva T, Spence DW, Bahammam AS, et al
. Sleep disorders as a cause of motor vehicle collisions. Int J Prev Med 2013;4:246-57.
Ulfberg J, Carter N, Edling C. Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health 2000;26:237-42.
Mulgrew AT, Ryan CF, Fleetham JA, Cheema R, Fox N, Koehoorn M, et al
. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Med 2007;9:42-53.
Leger D, Bayon V, Laaban JP, Philip P. Impact of sleep apnea on economics. Sleep Med Rev 2012;16:455-62.
Catarino R, Spratley J, Catarino I, Lunet N, Pais-Clemente M. Sleepiness and sleep-disordered breathing in truck drivers: Risk analysis of road accidents. Sleep Breath 2014;18:59-68.
AlGhanim N, Comondore VR, Fleetham J, Marra CA, Ayas NT. The economic impact of obstructive sleep apnea. Lung 2008;186:7-12.
Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 2004;27:453-8.
Smolensky MH, Di ML, Ohayon MM, Philip P. Sleep disorders, medical conditions, and road accident risk. Accid Anal Prev 2011;43:533-48.
Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, Menn S. Oral appliances for the treatment of snoring and obstructive sleep apnea: A review. Sleep 1995;18:501-10.
Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 2007;11:1-22.
Kushida CA, Nichols DA, Quan SF, Goodwin JL, White DP, Gottlieb DJ, et al
. The Apnea Positive Pressure Long-term Efficacy Study (APPLES): Rationale, design, methods, and procedures. J Clin Sleep Med 2006;2:288-300.
Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006;3:CD001106.
Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev 2006;4:CD004435.
Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: A randomized controlled trial. J Clin Sleep Med 2005;1:374-80.
Blanco J, Zamarron C, Abeleira Pazos MT, Lamela C, Suarez QD. Prospective evaluation of an oral appliance in the treatment of obstructive sleep apnea syndrome. Sleep Breath 2005;9:20-5.
Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: A randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743-8.
Hans MG, Nelson S, Luks VG, Lorkovich P, Baek SJ. Comparison of two dental devices for treatment of obstructive sleep apnea syndrome (OSAS). Am J Orthod Dentofacial Orthop 1997;111:562-70.
Johnston CD, Gleadhill IC, Cinnamond MJ, Gabbey J, Burden DJ. Mandibular advancement appliances and obstructive sleep apnoea: A randomized clinical trial. Eur J Orthod 2002;24:251-62.
Hoekema A, Stegenga B, Bakker M, Brouwer WH, de Bont LG, Wijkstra PJ, et al
. Simulated driving in obstructive sleep apnoea-hypopnoea; effects of oral appliances and continuous positive airway pressure. Sleep Breath 2007;11:129-38.
Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, et al
. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004;170:656-64.
Engleman HM, McDonald JP, Graham D, Lello GE, Kingshott RN, Coleman EL, et al
. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: Continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002;166:855-9.
Ferguson KA, Ono T, Lowe AA, al-Majed S, Love LL, Fleetham JA. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997;52:362-8.
Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996;109:1269-75.
Tan YK, L'Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, et al
. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: A randomized cross-over trial. Eur J Orthod 2002;24:239-49.
Aarab G, Lobbezoo F, Heymans MW, Hamburger HL, Naeije M. Long-term follow-up of a randomized controlled trial of oral appliance therapy in obstructive sleep apnea. Respiration 2011;82:162-8.
Ghazal A, Sorichter S, Jonas I, Rose EC. A randomized prospective long-term study of two oral appliances for sleep apnoea treatment. J Sleep Res 2009;18:321-8.
Findley L, Smith C, Hooper J, Dineen M, Suratt PM. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 2000;161:857-9.
George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001;56:508-12.
Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: Systematic review and meta-analysis. Sleep 2010;33:1373-80.
Antonopoulos CN, Sergentanis TN, Daskalopoulou SS, Petridou ET. Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: A meta-analysis. Sleep Med Rev 2011;15:301-10.
Komada Y, Nishida Y, Namba K, Abe T, Tsuiki S, Inoue Y. Elevated risk of motor vehicle accident for male drivers with obstructive sleep apnea syndrome in the Tokyo metropolitan area. Tohoku J Exp Med 2009;219:11-6.
Arai H, Furuta H, Kosaka K, Kaneda R, Koshino Y, Sano J, et al
. Changes in work performances in obstructive sleep apnea patients after dental appliance therapy. Psychiatry Clin Neurosci 1998;52:224-5.
Lavie P. Sleep habits and sleep disturbances in industrial workers in Israel: Main findings and some characteristics of workers complaining of excessive daytime sleepiness. Sleep 1981;4:147-58.
Pack AI, Maislin G, Staley B, Pack FM, Rogers WC, George CF, et al
. Impaired performance in commercial drivers: Role of sleep apnea and short sleep duration. Am J Respir Crit Care Med 2006;174:446-54.
Karimi M, Eder DN, Eskandari D, Zou D, Hedner JA, Grote L. Impaired vigilance and increased accident rate in public transport operators is associated with sleep disorders. Accid Anal Prev 2013;51:208-14.
Naismith S, Winter V, Gotsopoulos H, Hickie I, Cistulli P. Neurobehavioral functioning in obstructive sleep apnea: Differential effects of sleep quality, hypoxemia and subjective sleepiness. J Clin Exp Neuropsychol 2004;26:43-54.
Swanson LM, Arnedt JT, Rosekind MR, Belenky G, Balkin TJ, Drake C. Sleep disorders and work performance: Findings from the 2008 National Sleep Foundation Sleep in America poll. J Sleep Res 2011;20:487-94.
Ulfberg J, Carter N, Talback M, Edling C. Excessive daytime sleepiness at work and subjective work performance in the general population and among heavy snorers and patients with obstructive sleep apnea. Chest 1996;110:659-63.
Santos EH, de Mello MT, Pradella-Hallinan M, Luchesi L, Pires ML, Tufik S. Sleep and sleepiness among Brazilian shift-working bus drivers. Chronobiol Int 2004;21:881-8.
Koyama RG, Esteves AM, Oliveira e Silva, Lira FS, Bittencourt LR, Tufik S, et al
. Prevalence of and risk factors for obstructive sleep apnea syndrome in Brazilian railroad workers. Sleep Med 2012;13:1028-32.
Nena E, Tsara V, Steiropoulos P, Constantinidis T, Katsarou Z, Christaki P, et al
. Sleep-disordered breathing and quality of life of railway drivers in Greece. Chest 2008;134:79-86.
Rajaratnam SM, Barger LK, Lockley SW, Shea SA, Wang W, Landrigan CP, et al
. Sleep disorders, health, and safety in police officers. JAMA 2011;306:2567-78.
Mysliwiec V, Gill J, Lee H, Baxter T, Pierce R, Barr TL, et al
. Sleep disorders in US military personnel: A high rate of comorbid insomnia and obstructive sleep apnea. Chest 2013;144:549-57.
Lee YC, Eun YG, Shin SY, Kim SW. Prevalence of snoring and high risk of obstructive sleep apnea syndrome in young male soldiers in Korea. J Korean Med Sci 2013;28:1373-7.
Sanna A. Obstructive sleep apnoea, motor vehicle accidents, and work performance. Chron Respir Dis 2013;10:29-33.
Haja MH, West SD. Obstructive sleep apnoea and driving. Br J Hosp Med (Lond) 2011;72:366-7.
Mulgrew AT, Nasvadi G, Butt A, Cheema R, Fox N, Fleetham JA, et al
. Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea. Thorax 2008;63:536-41.
Findley LJ. Automobile driving in sleep apnea. Prog Clin Biol Res 1990;345:337-43.
Turkington PM, Sircar M, Saralaya D, Elliott MW. Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome. Thorax 2004;59:56-9.
Gieteling EW, Bakker MS, Hoekema A, Maurits NM, Brouwer WH, van der Hoeven JH. Impaired driving simulation in patients with Periodic Limb Movement Disorder and patients with Obstructive Sleep Apnea Syndrome. Sleep Med 2012;13:517-23.
Vakulin A, Baulk SD, Catcheside PG, Antic NA, van den Heuvel CJ, Dorrian J, et al
. Driving simulator performance remains impaired in patients with severe OSA after CPAP treatment. J Clin Sleep Med 2011;7:246-53.
Li G. Walter McNicholas: Sleep apnea-a disease calling for attention. J Thorac Dis 2014;6:170-3.
de Mello MT, Bittencourt LR, Cunha RC, Esteves AM, Tufik S. Sleep and transit in Brazil: New legislation. J Clin Sleep Med 2009;5:164-6.
MacLean AW, Davies DR, Thiele K. The hazards and prevention of driving while sleepy. Sleep Med Rev 2003;7:507-21.
Philip P, Sagaspe P, Lagarde E, Leger D, Ohayon MM, Bioulac B, et al
. Sleep disorders and accidental risk in a large group of regular registered highway drivers. Sleep Med 2010;11:973-9.
Howard ME, Desai AV, Grunstein RR, Hukins C, Armstrong JG, Joffe D, et al
. Sleepiness, sleep-disordered breathing, and accident risk factors in commercial vehicle drivers. Am J Respir Crit Care Med 2004;170:1014-21.
Braeckman L, Verpraet R, Van Risseghem M, Pevernagie D, De Bacquer D. Prevalence and correlates of poor sleep quality and daytime sleepiness in Belgian truck drivers. Chronobiol Int 2011;28:126-34.
Asaoka S, Namba K, Tsuiki S, Komada Y, Inoue Y. Excessive daytime sleepiness among Japanese public transportation drivers engaged in shiftwork. J Occup Environ Med 2010;52:813-8.
Mello MT, Santana MG, Souza LM, Oliveira PC, Ventura ML, Stampi C, et al
. Sleep patterns and sleep-related complaints of Brazilian interstate bus drivers. Braz J Med Biol Res 2000;33:71-7.
Rodenstein D. Driving in Europe: The need of a common policy for drivers with obstructive sleep apnoea syndrome. J Sleep Res 2008;17:281-4.
Horne JA, Reyner LA. Sleep related vehicle accidents. BMJ 1995;310:565-7.
Findley LJ, Suratt PM. Serious motor vehicle crashes: The cost of untreated sleep apnoea. Thorax 2001;56:505.
Lavie P. Incidence of sleep apnea in a presumably healthy working population: A significant relationship with excessive daytime sleepiness. Sleep 1983;6:312-8.
Akkoyunlu ME, Altin R, Kart L, Atalay F, Ornek T, Bayram M, et al
. Investigation of obstructive sleep apnoea syndrome prevalence among long-distance drivers from Zonguldak, Turkey. Multidiscip Respir Med 2013;8:10.
Torzsa P, Keszei A, Kalabay L, Vamos EP, Zoller R, Mucsi I, et al
. Socio-demographic characteristics, health behaviour, co-morbidity and accidents in snorers: A population survey. Sleep Breath 2011;15:809-18.
Lindberg E, Carter N, Gislason T, Janson C. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med 2001;164:2031-5.
Masa Jimenez JF, Rubio GM, Findley LJ, Riesco Miranda JA, Sojo GA, Disdier VC. Sleepy drivers have a high frequency of traffic accidents related to respiratory effort-related arousals. Arch Bronconeumol 2003;39:153-8.
Powers CR, Frey WC. Maintenance of wakefulness test in military personnel with upper airway resistance syndrome and mild to moderate obstructive sleep apnea. Sleep Breath 2009;13:253-8.
George CF. Sleep apnea, alertness, and motor vehicle crashes. Am J Respir Crit Care Med 2007;176:954-6.
Krieger J, Meslier N, Lebrun T, Levy P, Phillip-Joet F, Sailly JC, et al
. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: A prospective study. The Working Group ANTADIR, Paris and CRESGE, Lille, France. Association Nationale de Traitement a Domicile des Insuffisants Respiratoires. Chest 1997;112:1561-6.
Teran SJ, Moreno G, Rodenstein DO. Sleep medicine and transport workers. Medico-social aspects with special reference to sleep apnoea syndrome. Arch Bronconeumol 2010;46:143-7.
Parks P, Durand G, Tsismenakis AJ, Vela-Bueno A, Kales S. Screening for obstructive sleep apnea during commercial driver medical examinations. J Occup Environ Med 2009;51:275-82.
Pliska BT, Almeida F. Effectiveness and outcome of oral appliance therapy. Dent Clin North Am 2012;56:433-44.
Hoekema A, Doff MH, de Bont LG, van der Hoeven JH, Wijkstra PJ, Pasma HR, et al
. Predictors of obstructive sleep apnea-hypopnea treatment outcome. J Dent Res 2007;86:1181-6.
Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: A review. Sleep 2006;29:244-62.
Vanderveken OM, Braem MJ, Dieltjens M, De Backer WA, Van de Heyning PH. Objective measurement of the therapeutic effectiveness of continuous positive airway pressure versus oral appliance therapy for the treatment of obstructive sleep apnea. Am J Respir Crit Care Med 2013;188:1162.
Hiestand D, Phillips B. Obstructive sleep apnea syndrome: Assessing and managing risk in the motor vehicle operator. Curr Opin Pulm Med 2011;17:412-8.
Strohl KP, Brown DB, Collop N, George C, Grunstein R, Han F, et al
. An official American Thoracic Society Clinical Practice Guideline: Sleep apnea, sleepiness, and driving risk in noncommercial drivers. An update of a 1994 Statement. Am J Respir Crit Care Med 2013;187:1259-66.
Kristo D, Corcoran T, O'Connell N, Thomas K, Strollo P. The potential for delivery of particulate matter through positive airway pressure devices (CPAP/BPAP). Sleep Breath 2012;16:193-8.
Hoffman B, Wingenbach DD, Kagey AN, Schaneman JL, Kasper D. The long-term health plan and disability cost benefit of obstructive sleep apnea treatment in a commercial motor vehicle driver population. J Occup Environ Med 2010;52:473-7.
Sjosten N, Vahtera J, Salo P, Oksanen T, Saaresranta T, Virtanen M, et al
. Increased risk of lost workdays prior to the diagnosis of sleep apnea. Chest 2009;136:130-6.
Potts KJ, Butterfield DT, Sims P, Henderson M, Shames CB. Cost savings associated with an education campaign on the diagnosis and management of sleep-disordered breathing: A retrospective, claims-based US study. Popul Health Manag 2013;16:7-13.
Tarasiuk A, Greenberg-Dotan S, Brin YS, Simon T, Tal A, Reuveni H. Determinants affecting health-care utilization in obstructive sleep apnea syndrome patients. Chest 2005;128:1310-4.
Tarasiuk A, Reuveni H. The economic impact of obstructive sleep apnea. Curr Opin Pulm Med 2013;19:639-644.
Kapur V, Blough DK, Sandblom RE, Hert R, de Maine JB, Sullivan SD, et al
. The medical cost of undiagnosed sleep apnea. Sleep 1999;22:749-55.
Bahammam A, Delaive K, Ronald J, Manfreda J, Roos L, Kryger MH. Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep 1999;22:740-7.
Albarrak M, Banno K, Sabbagh AA, Delaive K, Walld R, Manfreda J, et al
. Utilization of healthcare resources in obstructive sleep apnea syndrome: A 5-year follow-up study in men using CPAP. Sleep 2005;28:1306-11.
Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, et al
. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: A randomized controlled trial. Am J Respir Crit Care Med 2013;187:879-87.
Pelletier-Fleury N, Meslier N, Gagnadoux F, Person C, Rakotonanahary D, Ouksel H, et al
. Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome. Eur Respir J 2004;23:53-60.
Tan MC, Ayas NT, Mulgrew A, Cortes L, FitzGerald JM, Fleetham JA, et al
. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia. Can Respir J 2008;15:159-65.
Sonnad SS, Moyer CA, Patel S, Helman JI, Garetz SL, Chervin RD. A model to facilitate outcome assessment of obstructive sleep apnea. Int J Technol Assess Health Care 2003;19:253-60.
Weatherly HL, Griffin SC, Mc Daid C, Duree KH, Davies RJ, Stradling JR, et al
. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome. Int J Technol Assess Health Care 2009;25:26-34.
Sadatsafavi M, Marra CA, Ayas NT, Stradling J, Fleetham J. Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea. Sleep Breath 2009;13:241-52.
|This article has been cited by|
||RSSDI clinical practice recommendations for screening, diagnosis, and treatment in type 2 diabetes mellitus with obstructive sleep apnea
| ||Vijay Viswanathan, Nagarajan Ramakrishnan, Banshi Saboo, Sanjay Agarwal |
| ||International Journal of Diabetes in Developing Countries. 2021; 41(1): 4 |
|[Pubmed] | [DOI]|